INTRODUCTION: The need to detect pancreatic cancer at earlier stages is undisputed. We recorded the signs and symptoms of patients presenting with exocrine pancreatic cancer and evaluated their association with clinical characteristics such as tumour site and disease stage. PATIENTS AND METHODS: All patients (n = 185) with exocrine pancreatic cancer newly diagnosed at five general hospitals in Eastern Spain were prospectively recruited over 5 years. Symptoms were elicited through personal interviews and signs were recorded by the attending physician on admission. RESULTS: At diagnosis, one third of tumours of the pancreas head were in stage I and another third in stage IV. None of the tumours of the body and tail were in stage I, and over 80% were in stage IV (p < 0.001) . At presentation, the most frequent symptoms were asthenia (86%), anorexia (85%), weight-loss (85%), abdominal pain (79%), and choluria (59%). Cholestatic symptoms were more common in tumours affecting only the pancreatic head (p < 0.001) . There was a clear trend toward more localized tumours with increasing numbers of cholestatic signs (p < 0.001) . Asthenia, anorexia and weight-loss were unrelated to stage. An increased symptom-to-diagnosis interval was associated with more advanced stage (p = 0.048). CONCLUSIONS: Proper attention to signs and symptoms, especially cholestasis, may help identify patients with pancreatic cancer at an earlier stage. Results also provide a current picture of the semiology of pancreatic cancer which could be of use in studies on the potential of proteomic tests in the early detection of this neoplasm.
INTRODUCTION: The need to detect pancreatic cancer at earlier stages is undisputed. We recorded the signs and symptoms of patients presenting with exocrine pancreatic cancer and evaluated their association with clinical characteristics such as tumour site and disease stage. PATIENTS AND METHODS: All patients (n = 185) with exocrine pancreatic cancer newly diagnosed at five general hospitals in Eastern Spain were prospectively recruited over 5 years. Symptoms were elicited through personal interviews and signs were recorded by the attending physician on admission. RESULTS: At diagnosis, one third of tumours of the pancreas head were in stage I and another third in stage IV. None of the tumours of the body and tail were in stage I, and over 80% were in stage IV (p < 0.001) . At presentation, the most frequent symptoms were asthenia (86%), anorexia (85%), weight-loss (85%), abdominal pain (79%), and choluria (59%). Cholestatic symptoms were more common in tumours affecting only the pancreatic head (p < 0.001) . There was a clear trend toward more localized tumours with increasing numbers of cholestatic signs (p < 0.001) . Asthenia, anorexia and weight-loss were unrelated to stage. An increased symptom-to-diagnosis interval was associated with more advanced stage (p = 0.048). CONCLUSIONS: Proper attention to signs and symptoms, especially cholestasis, may help identify patients with pancreatic cancer at an earlier stage. Results also provide a current picture of the semiology of pancreatic cancer which could be of use in studies on the potential of proteomic tests in the early detection of this neoplasm.
Authors: M Porta; N Malats; L Guarner; A Carrato; J Rifà; A Salas; J M Corominas; M Andreu; F X Real Journal: J Epidemiol Community Health Date: 1999-11 Impact factor: 3.710
Authors: Emanuel F Petricoin; Kathryn C Zoon; Elise C Kohn; J Carl Barrett; Lance A Liotta Journal: Nat Rev Drug Discov Date: 2002-09 Impact factor: 84.694
Authors: E Weiderpass; T Partanen; R Kaaks; H Vainio; M Porta; T Kauppinen; A Ojajärvi; P Boffetta; N Malats Journal: Scand J Work Environ Health Date: 1998-06 Impact factor: 5.024
Authors: Douglas S Swords; Mary C Mone; Chong Zhang; Angela P Presson; Sean J Mulvihill; Courtney L Scaife Journal: J Gastrointest Surg Date: 2015-08-19 Impact factor: 3.452
Authors: Elizabeth Won; Kenneth H Yu; Ali Shamseddine; Leonard Saltz; Deborah Mukherjee; Ali Haydar; Ashwaq El-Olayan; Sally Temraz; Mohamed Naghy; Dorothy Makanjoula; Eileen M O'Reilly; Ghassan K Abou-Alfa Journal: Gastrointest Cancer Res Date: 2013-03
Authors: Jyoti Narayanswami; Daniel A Smith; Michael Enzerra; Amir Ata Rahnemai-Azar; Elias Kikano; Nikhil H Ramaiya Journal: Emerg Radiol Date: 2019-02-04
Authors: Marta Crous-Bou; Immaculata De Vivo; Miquel Porta; José A Pumarega; Tomàs López; Joan Alguacil; Eva Morales; Núria Malats; Juli Rifà; David J Hunter; Francisco X Real Journal: Dig Dis Sci Date: 2008-03-18 Impact factor: 3.199